Cargando…
Adenosine-induced splenic switch-off on [(15)O]H(2)O PET perfusion for the assessment of vascular vasodilatation
BACKGROUND: Splenic switch-off (SSO) is a marker of adequate adenosine-induced vasodilatation on cardiac magnetic resonance perfusion imaging. We evaluate the feasibility of quantitative assessment of SSO in myocardial positron emission tomography (PET) perfusion imaging using [(15)O]H(2)O. METHODS:...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635971/ https://www.ncbi.nlm.nih.gov/pubmed/37943363 http://dx.doi.org/10.1186/s13550-023-01045-7 |
_version_ | 1785133109615788032 |
---|---|
author | Inkinen, Satu Irene Hippeläinen, Eero Uusitalo, Valtteri |
author_facet | Inkinen, Satu Irene Hippeläinen, Eero Uusitalo, Valtteri |
author_sort | Inkinen, Satu Irene |
collection | PubMed |
description | BACKGROUND: Splenic switch-off (SSO) is a marker of adequate adenosine-induced vasodilatation on cardiac magnetic resonance perfusion imaging. We evaluate the feasibility of quantitative assessment of SSO in myocardial positron emission tomography (PET) perfusion imaging using [(15)O]H(2)O. METHODS: Thirty patients underwent [(15)O]H(2)O PET perfusion with adenosine stress. Time-activity curves, as averaged standardized uptake values (SUV(avg)), were extracted from dynamic PET for spleen and liver. Maximum SUV(avg), stress and rest spleen-to-liver ratio (SLR), and the splenic activity concentration ratio (SAR) were computed. Optimal cut-off values for SSO assessment were estimated from receiver operating characteristics (ROC) curve for maximum SUV(avg) and SLR. Also, differences between coronary artery disease, myocardial ischemia, beta-blockers, and diabetes were assessed. Data are presented as median [interquartile range]. RESULTS: In concordance with the SSO phenomenon, both the spleen maximum SUV(avg) and SLR were lower in adenosine stress when compared to rest perfusion (8.1 [6.5, 9.2] versus 16.4 [13.4, 19.0], p < 0.001) and (0.81 [0.63, 1.08] versus 1.86 [1.73, 2.06], p < 0.001), respectively. During adenosine stress, the SSO effect was most prominent 40–160 s after radiotracer injection. Cut-off values of 12.6 and 1.57 for maximum SUV(avg) and SLR, respectively, were found based on ROC analysis. No differences in SAR, SLR(Rest), or SLR(Stress) were observed in patients with coronary artery disease, myocardial ischemia, or diabetes. CONCLUSIONS: SSO can be quantified from [(15)O]H(2)O PET perfusion and used as a marker for adequate adenosine-induced vasodilatation response. In contrary to other PET perfusion tracers, adenosine-induced SSO is time dependent with [(15)O]H(2)O. |
format | Online Article Text |
id | pubmed-10635971 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-106359712023-11-11 Adenosine-induced splenic switch-off on [(15)O]H(2)O PET perfusion for the assessment of vascular vasodilatation Inkinen, Satu Irene Hippeläinen, Eero Uusitalo, Valtteri EJNMMI Res Original Research BACKGROUND: Splenic switch-off (SSO) is a marker of adequate adenosine-induced vasodilatation on cardiac magnetic resonance perfusion imaging. We evaluate the feasibility of quantitative assessment of SSO in myocardial positron emission tomography (PET) perfusion imaging using [(15)O]H(2)O. METHODS: Thirty patients underwent [(15)O]H(2)O PET perfusion with adenosine stress. Time-activity curves, as averaged standardized uptake values (SUV(avg)), were extracted from dynamic PET for spleen and liver. Maximum SUV(avg), stress and rest spleen-to-liver ratio (SLR), and the splenic activity concentration ratio (SAR) were computed. Optimal cut-off values for SSO assessment were estimated from receiver operating characteristics (ROC) curve for maximum SUV(avg) and SLR. Also, differences between coronary artery disease, myocardial ischemia, beta-blockers, and diabetes were assessed. Data are presented as median [interquartile range]. RESULTS: In concordance with the SSO phenomenon, both the spleen maximum SUV(avg) and SLR were lower in adenosine stress when compared to rest perfusion (8.1 [6.5, 9.2] versus 16.4 [13.4, 19.0], p < 0.001) and (0.81 [0.63, 1.08] versus 1.86 [1.73, 2.06], p < 0.001), respectively. During adenosine stress, the SSO effect was most prominent 40–160 s after radiotracer injection. Cut-off values of 12.6 and 1.57 for maximum SUV(avg) and SLR, respectively, were found based on ROC analysis. No differences in SAR, SLR(Rest), or SLR(Stress) were observed in patients with coronary artery disease, myocardial ischemia, or diabetes. CONCLUSIONS: SSO can be quantified from [(15)O]H(2)O PET perfusion and used as a marker for adequate adenosine-induced vasodilatation response. In contrary to other PET perfusion tracers, adenosine-induced SSO is time dependent with [(15)O]H(2)O. Springer Berlin Heidelberg 2023-11-09 /pmc/articles/PMC10635971/ /pubmed/37943363 http://dx.doi.org/10.1186/s13550-023-01045-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Research Inkinen, Satu Irene Hippeläinen, Eero Uusitalo, Valtteri Adenosine-induced splenic switch-off on [(15)O]H(2)O PET perfusion for the assessment of vascular vasodilatation |
title | Adenosine-induced splenic switch-off on [(15)O]H(2)O PET perfusion for the assessment of vascular vasodilatation |
title_full | Adenosine-induced splenic switch-off on [(15)O]H(2)O PET perfusion for the assessment of vascular vasodilatation |
title_fullStr | Adenosine-induced splenic switch-off on [(15)O]H(2)O PET perfusion for the assessment of vascular vasodilatation |
title_full_unstemmed | Adenosine-induced splenic switch-off on [(15)O]H(2)O PET perfusion for the assessment of vascular vasodilatation |
title_short | Adenosine-induced splenic switch-off on [(15)O]H(2)O PET perfusion for the assessment of vascular vasodilatation |
title_sort | adenosine-induced splenic switch-off on [(15)o]h(2)o pet perfusion for the assessment of vascular vasodilatation |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635971/ https://www.ncbi.nlm.nih.gov/pubmed/37943363 http://dx.doi.org/10.1186/s13550-023-01045-7 |
work_keys_str_mv | AT inkinensatuirene adenosineinducedsplenicswitchoffon15oh2opetperfusionfortheassessmentofvascularvasodilatation AT hippelaineneero adenosineinducedsplenicswitchoffon15oh2opetperfusionfortheassessmentofvascularvasodilatation AT uusitalovaltteri adenosineinducedsplenicswitchoffon15oh2opetperfusionfortheassessmentofvascularvasodilatation |